M&A Deal Summary

H2 Equity Partners and Lloyds TSB Development Capital Acquire NRS Healthcare

On December 12, 2014, private equity firms H2 Equity Partners and Lloyds TSB Development Capital acquired medical products company NRS Healthcare from Lloyds TSB Development Capital

Acquisition Highlights
  • This is H2 Equity Partners’ 2nd and Lloyds TSB Development Capital’s 5th transaction in the Medical Products sector.
  • This is H2 Equity Partners’ 5th and Lloyds TSB Development Capital’s 153rd transaction in the United Kingdom.
Investment Fate
  • NRS Healthcare was sold to a consortium of financial buyers in 2019.

M&A Deal Summary
Date 2014-12-12
Target NRS Healthcare
Sector Medical Products
Buyer(s) H2 Equity Partners
Lloyds TSB Development Capital
Sellers(s) Lloyds TSB Development Capital
Deal Type Secondary Buyout

Target

NRS Healthcare

Leicestershire, United Kingdom
NRS Healthcare is a provider of community equipment, wheelchair, and clinical services to the NHS and local authorities. NRS Healthcare is based in Leicestershire, United Kingdom.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 2

Buyer

H2 Equity Partners

Amsterdam, Netherlands

Investor Investor Investor

Category Private Equity Firm
Founded 1991
PE ASSETS 500M EUR
Size Middle-Market
Type Sector Agnostic
DESCRIPTION
H2 Equity Partners' Amsterdam headquarters.
H2 Equity Partners' Amsterdam headquarters.

H2 Equity Partners is an independent private equity group focused on mid-sized turnaround-and-growth investments in the Benelux, Germany, and the UK. H2 looks for businesses facing operational, financial and/or managerial challenges, or sectors 'poised for consolidation'. H2 is a generalist investor, with no specific areas of interest. However, in the past, the firm has targeted opportunities in paper/board, steel, healthcare, media/communications, building products, consumer products, and fashion. H2 can invest in the rang of €5 to €25 million per transaction. H2 Equity Partners was formed in 1991 and has offices in Amsterdam, Munich, and London.

DEAL STATS #
Overall 29 of 60
Sector (Medical Products) 2 of 5
Type (Secondary Buyout) 1 of 9
Country (United Kingdom) 5 of 14
Year (2014) 3 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2014-07-07 Workx Equipment Rental

Zoetermeer, Netherlands

Workx (previously Jaston Groep) is active in the building equipment rental market in the Netherlands, focusing on contractors and related companies. Workx focuses on the B2B market, offering a multi-specialist approach, a high service level and high quality rental fleet. The company has a 'General Rental' division and a 'Scaffolding' division. Workx has a total of 45 depots in the Netherlands, and originates from the combination of a number of regional general rental and scaffolding players: PR Verhuur, Cramo NL, AA Verhuurcentrale, Steimach, Amarent, HuurCenter, Bollen Verhuur, Roos Verhuur, Jaston Steigerbouw, DSS, Dokter Steigerbouw and Hi-Reach.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2014-12-29 Assembléon Netherlands BV

La Vedhoven, Netherlands

Assembléon is a Pick-and-Place equipment producer., The Netherlands. Assembléon has delivered over 6,000 placement machines to more than 1,000 customers around the world. Assembléon current holds a top-5 global market position and is considered the technological top of the industry.

Sell $98M
Buyer

Lloyds TSB Development Capital

London, United Kingdom

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 1981
PE ASSETS 2.0B USD
Size Middle-Market
Type Sector Agnostic
DESCRIPTION

Lloyds TSB Development Capital Ltd (LDC) is the private equity arm of Lloyds Banking Group Plc and invests in mid-market companies throughout the UK. LDC seeks high growth businesses with at least two years of profitability (greater than £1 million). The Firm looks to commit £2 to £100 million in companies generating at least £5 million in revenue. Areas of interest include cleantech/environmental, construction/property, financial services, healthcare, industrials, retail/consumer, support services, TMT and travel/leisure. Prospective transaction types includes acquisition financings, development capital, equity release, MBOs, MBIs, mergers, private placements, and secondary buy-outs. Lloyds TSB Development Capital Ltd was formed in 1981 and is based in London.

DEAL STATS #
Overall 161 of 304
Sector (Medical Products) 5 of 8
Type (Secondary Buyout) 26 of 56
Country (United Kingdom) 153 of 292
Year (2014) 15 of 16
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2014-12-05 Kirona Solutions

Cheshire, United Kingdom

Kirona Solutions Ltd. is mobile cloud platform that enables customers to store and access data securely off site. By hosting this software online rather than through a network, the cloud technology significantly reduces upfront costs whilst adding full scalability benefits.

Sell £20M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2014-12-19 Quantum Pharmaceutical

County Durham, United Kingdom

Quantum Pharmaceutical is a pharmaceutical manufacturer and supplier of unlicensed medicines and hard-to-source products, we offer an unrivaled range, backed by expert knowledge and exceptional customer service. Quantum Pharmaceutical was founded in 2004 and is based in County Durham, United kingdom.

Sell -

Seller(S) 1

SELLER

Lloyds TSB Development Capital

London, United Kingdom

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 1981
PE ASSETS 2.0B USD
Size Middle-Market
Type Sector Agnostic
DESCRIPTION

Lloyds TSB Development Capital Ltd (LDC) is the private equity arm of Lloyds Banking Group Plc and invests in mid-market companies throughout the UK. LDC seeks high growth businesses with at least two years of profitability (greater than £1 million). The Firm looks to commit £2 to £100 million in companies generating at least £5 million in revenue. Areas of interest include cleantech/environmental, construction/property, financial services, healthcare, industrials, retail/consumer, support services, TMT and travel/leisure. Prospective transaction types includes acquisition financings, development capital, equity release, MBOs, MBIs, mergers, private placements, and secondary buy-outs. Lloyds TSB Development Capital Ltd was formed in 1981 and is based in London.

DEAL STATS #
Overall 79 of 198
Sector (Medical Products) 3 of 5
Type (Secondary Buyout) 25 of 72
Country (United Kingdom) 76 of 192
Year (2014) 15 of 17
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2014-12-05 Kirona Solutions

Cheshire, United Kingdom

Kirona Solutions Ltd. is mobile cloud platform that enables customers to store and access data securely off site. By hosting this software online rather than through a network, the cloud technology significantly reduces upfront costs whilst adding full scalability benefits.

Sell £20M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2014-12-19 Quantum Pharmaceutical

County Durham, United Kingdom

Quantum Pharmaceutical is a pharmaceutical manufacturer and supplier of unlicensed medicines and hard-to-source products, we offer an unrivaled range, backed by expert knowledge and exceptional customer service. Quantum Pharmaceutical was founded in 2004 and is based in County Durham, United kingdom.

Sell -
Mergr

Product

Company

Legal